Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah Meneceur"'
Autor:
Hussein Ghazale, Chantal Ripoll, Nicolas Leventoux, Laurent Jacob, Safa Azar, Daria Mamaeva, Yael Glasson, Charles-Felix Calvo, Jean-Leon Thomas, Sarah Meneceur, Yvan Lallemand, Valérie Rigau, Florence E. Perrin, Harun N. Noristani, Brenda Rocamonde, Emmanuelle Huillard, Luc Bauchet, Jean-Philippe Hugnot
Publikováno v:
Stem Cell Reports, Vol 12, Iss 5, Pp 1159-1177 (2019)
Summary: Anamniotes, rodents, and young humans maintain neural stem cells in the ependymal zone (EZ) around the central canal of the spinal cord, representing a possible endogenous source for repair in mammalian lesions. Cell diversity and genes spec
Externí odkaz:
https://doaj.org/article/705f9ae190674326953c60e1d157bba2
Autor:
Sarah Meneceur, Steffen Löck, Volker Gudziol, Sandra Hering, Rebecca Bütof, Maximilian Rehm, Michael Baumann, Mechthild Krause, Cläre von Neubeck
Publikováno v:
Radiotherapy and Oncology. 183:109619
Autor:
Günter Niegisch, Sophia Thy, Michèle J. Hoffmann, Wolfgang A. Schulz, Sarah Meneceur, Anna L. Bartkowiak, Alexandra Hommel
Publikováno v:
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1376, p 1376 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1376, p 1376 (2021)
Simple Summary Muscle-invasive urothelial carcinoma of the bladder (UC) is treated with chemotherapies based on the DNA-damaging drug cisplatin, which only works temporarily due to the development of drug resistance. In this study, we show that it ma
Publikováno v:
Genes, Vol 12, Iss 260, p 260 (2021)
Genes
Volume 12
Issue 2
Genes
Volume 12
Issue 2
Since genes encoding epigenetic regulators are often mutated or deregulated in urothelial carcinoma (UC), they represent promising therapeutic targets. Specifically, inhibition of Class-I histone deacetylase (HDAC) isoenzymes induces cell death in UC
Autor:
Sarah, Meneceur, Annett, Linge, Matthias, Meinhardt, Sandra, Hering, Steffen, Löck, Rebecca, Bütof, Dietmar, Krex, Gabriele, Schackert, Achim, Temme, Michael, Baumann, Mechthild, Krause, Cläre, von Neubeck
Publikováno v:
Cancers 12(2020), 871
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 871, p 871 (2020)
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 871, p 871 (2020)
Glioblastoma is an aggressive brain tumour with a patient median survival of approximately 14 months. The development of innovative treatment strategies to increase the life span and quality of life of patients is hence essential. This requires the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0e813dc203d923ca46ea1653e5633a88
https://www.hzdr.de/publications/Publ-30881-1
https://www.hzdr.de/publications/Publ-30881-1